Overview
Optellum is a leader in the medical AI space, specifically focusing on early lung cancer diagnosis through its Virtual Nodule Clinic (VNC). The platform's technical architecture is built around the Lung Cancer Prediction (LCP) score, a deep-learning algorithm trained on one of the world's largest datasets of lung nodules with known outcomes. By 2026, Optellum has solidified its market position as the gold standard for clinical decision support in pulmonary departments, effectively bridging the gap between incidental nodule discovery and definitive treatment. The system utilizes advanced computer vision to analyze 3D CT scans, identifying radiological features invisible to the human eye to stratify patient risk. Unlike standard CAD (Computer-Aided Detection) tools, Optellum's LCP score provides a validated probability of malignancy, which is FDA 510(k) cleared. This enables clinicians to avoid unnecessary invasive biopsies for benign nodules while fast-tracking patients with high-risk lesions to life-saving treatment. The platform integrates directly into hospital PACS (Picture Archiving and Communication Systems) and EMR (Electronic Medical Record) workflows, utilizing HL7 and FHIR standards to ensure data portability and real-time clinical utility.